Amy Stevenson
Internal Medicine · Greensboro, NCNPI 1881625507
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 450 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Tris Pharma Inc at 26.9% of the total. Among internal medicine clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 450 payments — averaging $14.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$2K
- Neos Therapeutics, LP$1K
- Corium, LLC$971
- Ironshore Pharmaceuticals Inc.$898
- Supernus Pharmaceuticals, Inc.$892
- Takeda Pharmaceuticals U.S.A., Inc.$219
- plus $855 from 9 others
Across 2 payments — averaging $1800.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ironshore Pharmaceuticals Inc.$4K
What the payments were for
- Food & beverage$6,724100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 97 | $1,812 |
| Neos Therapeutics, LP | 100 | $1,084 |
| Corium, LLC | 52 | $971 |
| Ironshore Pharmaceuticals Inc. | 63 | $898 |
| Supernus Pharmaceuticals, Inc. | 61 | $892 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $219 |
| Adlon Therapeutics L.p. | 12 | $218 |
| Collegium Pharmaceutical, Inc. | 17 | $204 |
| Vertical Pharmaceuticals, LLC | 13 | $134 |
| Arbor Pharmaceuticals, Inc. | 7 | $102 |
| Noven Therapeutics, LLC | 6 | $99 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Rhodes Pharmaceuticals L.p. | 2 | $25 |
| Avion Pharmaceuticals | 1 | $21 |
| Shire North American Group Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$141
- Dyanavel XR$122
How this compares
$6,731 in reported general payments places this provider in the 90th percentile of 3,302 internal medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyvanseLisdexamfetamine Dimesylate | 16 | $5,981 |
| MydayisDextroamphetamine/Amphetamine | 12 | $3,980 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 61 | $1,664 |
| Methylphenidate ErMethylphenidate Hcl | 16 | $668 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 14 | $374 |
| Methylphenidate Hcl | 12 | $94 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $219 | $5,98116 claims |
| Shire North American Group IncMydayis | $20 | $3,98012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,302 internal medicine providers in North Carolina.
Other internal medicine in Greensboro
- Thomas BellGreensboro$29K
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Bhakti PaulRaleigh$536K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Millie LongChapel Hill$374K
- Marc JohnsonCharlotte$342K
- Christina CraterRaleigh$330K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.